Maternal vaccination with a novel chimeric glycoprotein formulated with a polymer-based adjuvant provides protection from human parainfluenza virus type 3 in newborn lambs.

MLA

Garg, R., et al. “Maternal Vaccination with a Novel Chimeric Glycoprotein Formulated with a Polymer-Based Adjuvant Provides Protection from Human Parainfluenza Virus Type 3 in Newborn Lambs.” Antiviral Research, vol. 162, Feb. 2019, pp. 54–60. EBSCOhost, https://doi.org/10.1016/j.antiviral.2018.12.010.

APA

Garg, R., Latimer, L., Gomis, S., Gerdts, V., Potter, A., & van Drunen Littel-van den Hurk, S. (2019). Maternal vaccination with a novel chimeric glycoprotein formulated with a polymer-based adjuvant provides protection from human parainfluenza virus type 3 in newborn lambs. Antiviral Research, 162, 54–60. https://doi.org/10.1016/j.antiviral.2018.12.010

Chicago

Garg, R, L Latimer, S Gomis, V Gerdts, A Potter, and S van Drunen Littel-van den Hurk. 2019. “Maternal Vaccination with a Novel Chimeric Glycoprotein Formulated with a Polymer-Based Adjuvant Provides Protection from Human Parainfluenza Virus Type 3 in Newborn Lambs.” Antiviral Research 162 (February): 54–60. doi:10.1016/j.antiviral.2018.12.010.